Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients von IRAVANI, M, EVAZI, M. R, GHAVAMZADEH, A, MOUSAVI, S. A, SHAMSHIRI, A. R, TAVAKOLI, M, ASHOURI, A, SAMIEE, S, CHAHARDOVALI, B, ALIMOGHADDAM, K, GHAFFARI, S. H

Volltext

Evaluation of normal tissue complications in breast cancer re-irradiation: a meta-analysis study von Amraee, A, Mokhayeri, Y, Gholami, M, Resane, S, Evazi, M R, Abbasi, M, Sadr, M, Shamsi, Sh, Tayebzadeh, P, Jahani, A, Darvish, L

Volltext

Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study von Amraee, A., Evazi, M. R., Shakeri, M., Roozbeh, N., Ghazanfarpour, M., Ghorbani, M., Ansari, J., Darvish, L.

Volltext

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients: Conditioning Regimens von Iravani, M, Evazi, M R, Mousavi, S A, Shamshiri, A R, Tavakoli, M, Ashouri, A, Samiee, S, Chahardovali, B, Alimoghaddam, K, Ghaffari, S H, Ghavamzadeh, A

Volltext